Clinical & Experimental Immunology · 1992 · 273 citations · 29 references
Life SciencesBiochemistryImmunologyClinical PharmacologyImmunopathologyImmunopharmacotherapyMalariaPlasma ProteinsProtein BindingAntimalarial AgentsImmunopathology Of MalariaMalaria ImmunologyTreatment Of Malaria
Two ELISAs for estimating mannan-binding protein (MBP) were constructed and the concentration of MBP in plasma was followed in patients undergoing major surgery and in patients having a malarial attack. In both cases increases of MBP in the plasma were observed. The relative increase and the kinetics varied from person to person. The concentration of MBP increased between 1.5- and three-fold following surgery. In some patients an increase was seen at day 1 whereas in others the increase was not observed until days 3-9. In the malaria patients an increased level of MBP was maintained during 30 days of treatment with chloroquine. The relative increase in MBP was independent of the presurgery or premalaria levels.
29
Molecular basis of opsonic defect in immunodeficient children
M. Sumiya, P Tabona, T Arai et al. · The Lancet · 1991 · 542 citations
ASSOCIATION OF LOW LEVELS OF MANNAN-BINDING PROTEIN WITH A COMMON DEFECT OF OPSONISATION
Michael Super, Jinhua Lu, Steffen Thiel et al. · The Lancet · 1989 · 496 citations